A detailed history of Trexquant Investment LP transactions in Insmed Inc stock. As of the latest transaction made, Trexquant Investment LP holds 111,682 shares of INSM stock, worth $7.96 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
111,682
Holding current value
$7.96 Million
% of portfolio
0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$62.0 - $79.01 $6.92 Million - $8.82 Million
111,682 New
111,682 $8.15 Million
Q1 2024

May 14, 2024

SELL
$25.72 - $29.94 $1.17 Million - $1.37 Million
-45,595 Reduced 43.23%
59,887 $1.62 Million
Q4 2023

Feb 09, 2024

SELL
$23.42 - $31.74 $4.44 Million - $6.02 Million
-189,511 Reduced 64.24%
105,482 $3.27 Million
Q3 2023

Nov 13, 2023

BUY
$19.86 - $26.93 $5.27 Million - $7.15 Million
265,457 Added 898.76%
294,993 $7.45 Million
Q2 2023

Aug 11, 2023

SELL
$16.44 - $21.1 $92,195 - $118,328
-5,608 Reduced 15.96%
29,536 $623,000
Q1 2023

May 15, 2023

SELL
$16.26 - $21.73 $917,795 - $1.23 Million
-56,445 Reduced 61.63%
35,144 $599,000
Q4 2022

Feb 13, 2023

BUY
$16.98 - $23.15 $506,869 - $691,050
29,851 Added 48.35%
91,589 $1.83 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $1.07 Million - $1.45 Million
51,296 Added 491.25%
61,738 $1.33 Million
Q2 2022

Aug 11, 2022

SELL
$17.07 - $25.71 $11,846 - $17,842
-694 Reduced 6.23%
10,442 $206,000
Q1 2022

May 13, 2022

SELL
$20.42 - $28.13 $246,898 - $340,119
-12,091 Reduced 52.06%
11,136 $262,000
Q4 2021

Feb 14, 2022

BUY
$25.89 - $33.45 $601,347 - $776,943
23,227 New
23,227 $633,000
Q3 2019

Nov 08, 2019

SELL
$15.49 - $25.78 $585,614 - $974,638
-37,806 Closed
0 $0
Q2 2019

Aug 09, 2019

SELL
$23.0 - $32.19 $200,353 - $280,407
-8,711 Reduced 18.73%
37,806 $968,000
Q1 2019

May 13, 2019

BUY
$13.91 - $31.15 $647,051 - $1.45 Million
46,517 New
46,517 $1.35 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.65B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.